N/A N=33 Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.
Warts · Plantar Wart · Common Wart
Primary: Diameter of the Wart — -0.12 cm
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=60 RCT for Innovating Stress-related eHealth
Posttraumatic Stress Disorder · Sexual Assault · Pain
Primary: Treatment Adherence/Acceptability Scale — 57.53 score on a scale
N/A N=94 Problem Solving Training for Care Partners of Adults With Traumatic Brain Injury
Care Partners of Patients With Traumatic Brain Injury (TBI)
Primary: Changes From T2 to T3 in the Patient Health Questionnaire (PHQ9) — 2.9; 1.5 change score on a scale
Phase 2 N=88 Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer
Stage I Lung Non-Small Cell Cancer AJCC v7 · Stage IA Lung Non-Small Cell Carcinoma AJCC v7 · Stage IB Lung Non-Small Cell Carcinoma AJCC v7
Primary: Major Pathologic Response (mPR) — 5; 8; 7; 11 Participants
N/A N=495 Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers
Dementia · Alzheimer Disease · Lewy Body Disease
Primary: Caregiver Mastery — 2.80; 2.80; 3.04; 2.90 score on a scale
N/A N=40 mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention
HIV Infections · Sexually Transmitted Diseases, Viral · Syphilis
Primary: The Number of Participants Who Are Able to Self-administer the DPP® HIV-Syphilis Test With mLab App Plus — 12 Participants
N/A N=97 Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation
Interstitial Cystitis
Primary: Number of Participants Designated as "Treatment Responders" Based on Global Response Assessment (GRA) — 31; 10 Participants
N/A N=18 Virtual Reality for Chronic Pain and Opioid Use Disorder Pilot
Chronic Pain · Opioid Use Disorder
Primary: Change in Pain Intensity — -1.38; 0.33 score on a scale — p=0.17
Phase 2 N=35 The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training.
Schizophrenia
Primary: Cognitive Functions: Matrics Consensus Cognitive Battery (MCCB), Greek Verbal Test — 12.09; 19.04; 7.71; 14.00 score on a scale — p=.00
Phase 2 N=25 Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes
Type 1 Diabetes Mellitus
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAE) — 9; 6; 4; 1 participants
N/A N=119 Neural Mechanisms Associated With Risk of Smoking Relapse
Nicotine Addiction
Primary: Days to Relapse — 3.95; 3.78 days
N/A N=81 Effectiveness of Intelligent Rehabilitation Robot Training System Combined With Repetitive Facilitative Exercise on Upper Limb Motor Function After Stroke: a Randomized Control Trial.
Stroke
Primary: Fugl-Meyer Assessment for Upper Extremity (FMA-UE) — 34.4; 34.9; 35.8; 49.0 score on a scale
N/A N=167 Brief Alcohol Intervention for School-to-Work Transitions
Binge Drinking
Primary: Timeline Follow Back Assessing Number of Standard Drinks — 8.93; 5.56 standard drinks/week
Phase 3 N=72 Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy
Traumatic Brain Injury · Fatigue · Cognitive Impairment
Primary: Lean Body Mass as Measured by Dual Energy X-Ray Absorptiometry (DEXA) at Baseline — 49.9; 49.6 kilograms
N/A N=70 Disease Management Platform for Heart Failure (DMP-HF)
Heart Failure
Primary: Feasibility of Implementation — 51; 51; 51 Participants